Organo Corporation
Stock Price Chart
2026/08/03 UpdatedPrice Trend
2026/08/03 UpdatedPrice & Trading Details
2026/08/03 UpdatedPRICE
TRADING
Analyst Recommendations 2 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/05/12 | ¥198.06 | ¥226.23 | +14.2% |
| 2026/02/03 | ¥167.06 | ¥140.73 | -15.8% |
| 2025/10/30 | ¥129.68 | ¥171.53 | +32.3% |
| 2025/08/04 | ¥91.92 | ¥79.25 | -13.8% |
Shareholder Composition
Updated 2026/08/01Major Holders
Updated 2026/08/01| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Perpetual Americas Funds Trust-JOHCM International Select Fund
|
525.9K | -14.33% | |
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
365.7K | +0.61% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
242.0K | +2.50% | |
|
LAZARD FUNDS INC-Lazard International Strategic Equity Portfolio
|
198.4K | +10.27% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
190.9K | 0.00% | |
|
TRANSAMERICA FUNDS-Transamerica International Small Cap Value
|
120.7K | -0.98% |
Dividend History
Updated 2026/08/02| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥105 | -42.9% |
| 2025 | ¥184 | +39.4% |
| 2024 | ¥132 | +78.4% |
| 2023 | ¥74 | +45.1% |
| 2022 | ¥51 | - |
Financial Performance
2026/08/02 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥112,069M | ¥132,426M | ¥150,356M | ¥163,269M |
| Gross Profit | ¥28,512M | ¥34,976M | ¥43,841M | ¥55,182M |
| Operating Income | ¥10,850M | ¥15,213M | ¥22,544M | ¥31,121M |
| Pretax Income | ¥12,823M | ¥16,194M | ¥23,873M | ¥32,604M |
| Net Income | ¥9,210M | ¥11,730M | ¥17,310M | ¥24,150M |
| EPS | ¥200.67 | ¥255.77 | ¥376.92 | ¥525.37 |
| Operating Margin | 9.68% | 11.49% | 14.99% | 19.06% |
| Balance Sheet | ||||
| Total Assets | ¥130,506M | ¥164,854M | ¥182,703M | ¥194,396M |
| Total Equity | ¥75,836M | ¥86,169M | ¥101,927M | ¥120,947M |
| Total Liabilities | ¥54,670M | ¥78,685M | ¥80,776M | ¥73,449M |
| Cash | ¥20,198M | ¥15,558M | ¥17,642M | ¥16,751M |
| Interest-bearing Debt | ¥15,628M | ¥33,019M | ¥36,465M | ¥22,557M |
| Equity Ratio | 58.11% | 52.27% | 55.79% | 62.22% |
| D/E Ratio | 0.21 | 0.38 | 0.36 | 0.19 |
| Cash Flow | ||||
| Operating CF | ¥10,787M | -¥18,536M | ¥3,726M | ¥21,100M |
| Investing CF | -¥1,520M | -¥1,309M | -¥1,415M | -¥2,130M |
| Financing CF | -¥2,586M | ¥14,706M | -¥641M | -¥20,821M |
| Free CF | ¥7,989M | -¥19,988M | ¥2,079M | ¥18,411M |
| Efficiency | ||||
| ROE | 12.14% | 13.61% | 16.98% | 19.97% |
| ROA | 7.06% | 7.12% | 9.47% | 12.42% |
Latest IR Information
-
Organo Corporation (6386) FY2027 Q1 Financial Summary
Disclosure of FY2027 Q1 results. Revenues, operating income, ordinary income, net income, and per-share information are presented in sections. Segment breakdowns and capital policy-related disclosures are provided in separate sections. YoY and QoQ comparisons may be included.
Read more -
Fiscal Year 2027 First Quarter Supplementary Financial Information
Presents the consolidated results for the first quarter of Fiscal Year 2027. Orders were 167,956 million yen, net sales were 177,654 million yen, and operating income was 37,648 million yen, with comparisons to the previous period and full-year outlook. Breakdowns...
Read more
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥20,450
Rating Score: 1.00 (Based on 2 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
Organo Corporation engages in water treatment engineering and performance product businesses in Japan, Taiwan, China, Southeast Asia, and internationally. The company offers pure water systems, such as reverse osmosis (RO) systems, regenerative automatic and manual pure water systems, electric regeneration pure water systems, desktop and cabinet-type pure water systems, electrodeionization high-purity water systems, cartridge water purifiers, and two-stage RO systems; ultrapure water systems, including desktop and cabinet-type ultrapure water systems, and final polishing units; and other equipment comprising homogenizers, electroconductivity and resistivity meters, and ion exchange filters, as well as marine scrubber wastewater treatment and continuous aerobic granular sludge systems. It also provides water, wastewater, and RO water treatment chemicals; industrial filters consisting of micro filter, sanitary, polypropylene, and plastic housings, as well as micro filters; and commercial water purifiers. In addition, the company offers ultrapure and multi-functional water production systems, wastewater treatment systems, ultra pure ion exchange resin for purifying electronic materials, valuable resource recovery systems, and organic solvent refining systems; purified and UF water production and supply systems, water for injection production and supply systems, and pharmaceutical water system consulting services; water supply and sewage treatment facility products; condensate filters and demineralizers, reactor water and fuel pool cleanup, makeup water, and waste water treatment systems; and sugar refining and decolorization, sugar desalination, amino and acidic sugar refining, and sugar separation equipment. The company was formerly known as Japan Organo Co., Ltd. and changed its name to Organo Corporation in 1966. Organo Corporation was incorporated in 1941 and is headquartered in Koto, Japan.